0000897069-23-001044.txt : 20230801
0000897069-23-001044.hdr.sgml : 20230801
20230801171016
ACCESSION NUMBER: 0000897069-23-001044
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221206
FILED AS OF DATE: 20230801
DATE AS OF CHANGE: 20230801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Priebe Waldemar
CENTRAL INDEX KEY: 0001678516
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39126
FILM NUMBER: 231132728
MAIL ADDRESS:
STREET 1: 2575 W. BELLFORT
STREET 2: SUITE 333
CITY: HOUSTON
STATE: TX
ZIP: 77054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CNS Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001729427
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 822318545
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 WEST LOOP SOUTH
STREET 2: SUITE 900
CITY: HOUSTON
STATE: TX
ZIP: 77027
BUSINESS PHONE: 1-800-946-9185
MAIL ADDRESS:
STREET 1: 2100 WEST LOOP SOUTH
STREET 2: SUITE 900
CITY: HOUSTON
STATE: TX
ZIP: 77027
4
1
form4.xml
X0508
4
2022-12-06
true
0001729427
CNS Pharmaceuticals, Inc.
CNSP
0001678516
Priebe Waldemar
C/O CNS PHARMACEUTICALS, INC.
100 WEST LOOP SOUTH, SUITE 900
HOUSTON
TX
77027
true
true
Common Stock
2022-12-06
4
S
0
5500
2.47
D
245605
I
See footnote
Common Stock
2022-12-07
4
S
0
5500
2.46
D
240105
I
See footnote
Common Stock
2022-12-08
4
S
0
5500
2.4
D
234605
I
See footnote
Common Stock
2022-12-09
4
S
0
2798
2.43
D
231807
I
See footnote
Common Stock
2023-03-10
4
S
0
5000
1.29
D
226807
I
See footnote
Common Stock
2023-03-13
4
S
0
5000
1.3
D
221807
I
See footnote
Common Stock
2023-03-14
4
S
0
5000
1.35
D
216807
I
See footnote
Common Stock
2023-03-15
4
S
0
5000
1.22
D
211807
I
See footnote
Common Stock
2023-03-16
4
S
0
5000
1.24
D
206807
I
See footnote
Common Stock
2023-03-17
4
S
0
5000
1.13
D
201807
I
See footnote
Common Stock
2023-03-20
4
S
0
5000
1.08
D
196807
I
See footnote
Common Stock
2023-03-21
4
S
0
5000
1.1
D
191807
I
See footnote
Common Stock
2023-03-22
4
S
0
5000
1.08
D
186807
I
See footnote
Common Stock
2023-03-23
4
S
0
10000
1.08
D
176807
I
See footnote
Common Stock
2023-03-24
4
S
0
5000
1.08
D
171807
I
See footnote
Common Stock
2023-03-27
4
S
0
5000
1.09
D
166807
I
See footnote
Common Stock
2023-03-28
4
S
0
10000
1.04
D
156807
I
See footnote
Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc.
/s/ Waldemar Priebe
2023-08-01